Kymera Therapeutics KYMR
NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Kymera Therapeutics (KYMR) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Analysis

Kymera Therapeutics (KYMR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - 1.77 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.77 Bn
Jun 30, 2026 1.65 Bn
Mar 31, 2026 1.67 Bn
Dec 31, 2025 1.74 Bn
Sep 30, 2025 1.10 Bn
Jun 30, 2025 1.13 Bn
Mar 31, 2025 918.31 Mn
Dec 31, 2024 978.04 Mn
Sep 30, 2024 1.03 Bn
Jun 30, 2024 826.02 Mn
Mar 31, 2024 868.25 Mn
Dec 31, 2023 575.76 Mn
Sep 30, 2023 552.38 Mn
Jun 30, 2023 581.95 Mn
Mar 31, 2023 613.91 Mn
Dec 31, 2022 603.13 Mn
Sep 30, 2022 638.47 Mn
Jun 30, 2022 523.42 Mn
Mar 31, 2022 563.06 Mn
Dec 31, 2021 605.91 Mn
API Access

Kymera Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KYMR&period=max&api_key=YOUR_API_KEY